Abstract | BACKGROUND: METHODS AND RESULTS: A total of 84 in-hospital <65-year old patients with advanced HF undergoing CRT-D were enrolled. Seventeen patients (20%) had been dependent on inotropes at the time of CRT-D implantation, and 17 suffered cardiac death within a year. Both inotrope dependence and elevated plasma levels of B-type natriuretic peptide (BNP) (>690 pg/mL) at the time of CRT-D implantation were independent predictors of cardiac death within a year by Cox regression analyses (P < 0.05 for both). These 2 parameters could significantly stratify 1-year ventricular assist device (VAD)-free survival: inotrope-free low (1) or high BNP (2), or inotrope-dependent low (3) or high BNP groups (4) (98, 77, 57, and 17%, respectively, P < 0.001). In contrast, there were no significant differences in actual 1-year survival among the four groups. CONCLUSION: Patients dependent on inotropes sometimes receive CRT-D therapy as the last treatment resort in clinical practice, but LVAD implantation should be considered instead of CRT-D in advanced HF patients because of their poor prognosis with CRT-D therapy.
|
Authors | Teruhiko Imamura, Koichiro Kinugawa, Daisuke Nitta, Masaru Hatano, Issei Komuro |
Journal | Journal of cardiac failure
(J Card Fail)
Vol. 21
Issue 6
Pg. 535-8
(Jun 2015)
ISSN: 1532-8414 [Electronic] United States |
PMID | 25930086
(Publication Type: Journal Article)
|
Copyright | Copyright © 2015 Elsevier Inc. All rights reserved. |
Chemical References |
- Cardiotonic Agents
- Natriuretic Peptide, Brain
|
Topics |
- Adult
- Cardiac Resynchronization Therapy
(adverse effects, methods)
- Cardiotonic Agents
(therapeutic use)
- Defibrillators, Implantable
- Echocardiography
- Female
- Heart Failure
(diagnosis, mortality, physiopathology, therapy)
- Humans
- Japan
- Male
- Middle Aged
- Natriuretic Peptide, Brain
(analysis)
- Prognosis
- Severity of Illness Index
- Survival Analysis
- Treatment Outcome
|